[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$enta](/topic/$enta)

### Sentiment: XXX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$enta/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$enta/time-series/sentiment.tsv)  
**Current Value**: XXX%  
**Daily Average**: XX%  
**1 Week**: XX% no change  
**1 Month**: XXX% +25%  
**1-Year High**: XXX% on 2025-04-28  
**1-Year Low**: XX% on 2025-09-06  

**Most Supportive Themes**
- **Positive News and Data Presentations:** (40%) Enanta Pharmaceuticals ($ENTA) is presenting Phase X results for RSV treatments, generating positive sentiment.
- **Volume and Momentum Indicators:** (25%) Mentions of $ENTA on volume lists and in conjunction with positive technical indicators.
  
**Most Critical Themes**
- **General Market Sentiment:** (15%)  General market sentiment is mixed, with some analysts providing positive and negative comments.
- **Stock Offering:** (10%)  Enanta Pharmaceuticals is seeking growth capital through a public stock offering.
  
Network engagement breakdown:  
| Network | Positive | %  | Neutral | %   | Negative | %  |
| ------- | -------- | -  | ------- | -   | -------- | -  |
| X       | XX       | X% | XXX     | XX% | X        | X% |
|         |          |    |         |     |          |    |
| Total   | XX       | X% | XXX     | XX% | X        | X% |